1. 詹启敏 中国 北京大学 中国工程院院士 Genomic and epigenomic evolution of acquired resistance to combination therapy in esophageal squamou..
2. 赫捷 中国 中国医学科学院 中国科学院院士 Survival Nomogram for Stage IB Non-Small-Cell Lung Cancer Patients, Based on the SEER Database and a..
3. Arul M. Chinnaiyan 美国 University of Michigan 2020美国科学院院士;2009美国医学院院士 The Potential of Circular RNAs as Cancer Biomarkers
4. Akinobu,Taketomi 日本 Hokkaido University SGLT2 is upregulated to acquire cisplatin resistance and SGLT2 inhibition reduces cisplatin resistan..
5. Christopher I,Amos 美国 Baylor College of Medicine Venous thromboembolism risk in cancer patients receiving first-line immune checkpoint inhibitor vers..
6. Christopher R,Flowers 美国 University of Texas MD Anderson Cancer Center Venous thromboembolism risk in cancer patients receiving first-line immune checkpoint inhibitor vers..
7. Joe Y,Chang 美国 University of Texas MD Anderson Cancer Center Neoadjuvant immunotherapy for advanced, resectable non-small cell lung cancer: A systematic review a..
8. Andrea,Cossarizza 意大利 University of Modena & Reggio Emilia Circulating and Tumor-Associated Neutrophils in the Era of Immune Checkpoint Inhibitors: Dynamics, P..
9. Stephen Albert,Johnston 美国 Arizona State University Predicting response and toxicity to immune checkpoint inhibitors in lung cancer using antibodies to ..
10. 王洁 中国 中国医学科学院 Effectiveness of neoadjuvant immunochemotherapy compared to neoadjuvant chemotherapy in non-small ce..
11. 王洁 中国 中国医学科学院 Comprehensive Analyses and Immunophenotyping of LIM Domain Family Genes in Patients with Non-Small-C..
12. Guido,Sauter 德国 University of Hamburg Desmoglein 3 (Dsg3) expression in cancer: A tissue microarray study on 15,869 tumors
13. Kazim,Sahin 土耳其 Firat University The Use of Phytochemicals to Improve the Efficacy of Immune Checkpoint Inhibitors: Opportunities and..
14. Antonio,Giordano 美国 Temple University PD-1/PD-L1 immune-checkpoint blockade induces immune effector cell modulation in metastatic non-smal..
15. Pierfrancesco,Tassone 意大利 Magna Graecia University Catanzaro PD-1/PD-L1 immune-checkpoint blockade induces immune effector cell modulation in metastatic non-smal..
16. 黄钢 中国 上海健康医学院 博士生导师 Circular RNA EPB41 expression predicts unfavorable prognoses in NSCLC by regulating miR-486-3p/eIF5A..
17. Hamed,Mirzaei 伊朗 Kashan University Medicine Science Dysregulated expression and functions of microRNA-330 in cancers: A potential therapeutic target
18. Huo, Teh-Ia 中国 台北荣民总医院 Oncogenic circRNA C190 Promotes Non-Small Cell Lung Cancer via Modulation of the EGFR/ERK Pathway
19. Chiou, Shih-Hwa 中国 台北荣民总医院 Oncogenic circRNA C190 Promotes Non-Small Cell Lung Cancer via Modulation of the EGFR/ERK Pathway
20. 熊炜 中国 中南大学 Regulation of cancer progression by circRNA and functional proteins